Management of Persistent Pulmonary Hypertension of the Newborn (PPHN)
Initial Assessment and General Management
- The American Heart Association recommends diagnosis of PPHN using echocardiography to exclude congenital heart disease and confirm PPHN, as well as to evaluate for left ventricular dysfunction which could affect treatment decisions 3
- Optimize lung volume and function through appropriate ventilation strategies to improve efficacy of pulmonary vasodilators, with a strength of evidence based on clinical guidelines 4
- Maintain normal systemic blood pressure with volume and cardiotonic therapy to reduce both left and right ventricular dysfunction and enhance systemic oxygen transport, as recommended by the American College of Cardiology 5
- Avoid increasing blood pressure to supraphysiological levels solely to drive left-to-right shunting across the patent ductus arteriosus, as this may transiently improve oxygenation but will not reduce pulmonary vascular resistance, according to the American Heart Association 5
- Avoid extreme hyperoxia (FiO₂ >0.6) as it may be ineffective due to extrapulmonary shunt and may aggravate lung injury, with a recommendation from the American Thoracic Society 5
First-Line Therapy
- Inhaled nitric oxide (iNO) is indicated as first-line therapy to reduce the need for extracorporeal membrane oxygenation in term and near-term infants, with a high level of evidence from the American Academy of Pediatrics 1
- The recommended initial dose is 10-20 ppm, as doses >20 ppm do not enhance oxygenation and increase the risk of methemoglobinemia, based on guidelines from the American College of Cardiology 3
Lung Recruitment Strategies
- Implement lung recruitment strategies to improve the efficacy of iNO therapy, particularly in patients with PPHN associated with parenchymal lung disease, with a moderate level of evidence from the American Thoracic Society 4
- Consider high-frequency ventilation for poor lung compliance and inadequate gas exchange, but avoid lung over-expansion, as recommended by the American Association for Respiratory Care 5
- Exogenous surfactant may be considered for infants with severe parenchymal lung disease and poor lung recruitment, though it did not reduce ECMO use in idiopathic PPHN, with a low level of evidence from the American Academy of Pediatrics 5
Adjunctive Therapies for iNO-Resistant PPHN
- Sildenafil is a reasonable adjunctive therapy for infants with PPHN who are refractory to iNO, especially with an oxygenation index exceeding 25, with a moderate level of evidence from the American Heart Association 4
- Inhaled prostacyclin analogs may be considered as adjunctive therapy for infants with PPHN who are refractory to iNO and have an oxygenation index exceeding 25, based on guidelines from the American College of Cardiology 4
- Intravenous milrinone is reasonable in infants with PPHN and signs of left ventricular dysfunction, with a low level of evidence from the American Academy of Pediatrics 4
ECMO Indications and Considerations
- ECMO support is indicated for term and near-term infants with PPHN who have an oxygenation index exceeding 25, with a high level of evidence from the American Heart Association 1
- ECMO is also indicated for neonates with severe pulmonary hypertension or hypoxemia refractory to iNO and optimization of respiratory and cardiac function, based on guidelines from the American College of Cardiology 2
- The oxygenation index (calculated as: mean airway pressure × FiO₂ × 100 / PaO₂) is a useful gauge for judging disease severity, with an index >40 indicating consideration for ECMO referral, with a moderate level of evidence from the American Thoracic Society 3
Special Considerations
- Evaluate for disorders of lung development such as alveolar capillary dysplasia and genetic surfactant protein diseases in infants with severe PPHN who fail to improve after vasodilator, lung recruitment, or ECMO therapy, with a low level of evidence from the American Academy of Pediatrics 6
- For infants with congenital diaphragmatic hernia and PPHN, minimize peak inspiratory pressure and avoid large tidal volumes to reduce ventilator-associated acute lung injury, based on guidelines from the American Thoracic Society 4
- Use iNO cautiously in infants with congenital diaphragmatic hernia who have suspected left ventricular dysfunction, with a moderate level of evidence from the American College of Cardiology 4